EUTM file information

018742022

180 LIFE SCIENCES


August 3, 2022

Trademark Summary

The trademark application 180 LIFE SCIENCES was filed by 180 LIFE SCIENCES CORP., a U.S. corporation (the "Applicant"). Application under examination.

The application was filed in English (German was selected as the second language).


Goods And Services

  • The mark was filed in class 5 with following description of goods:
    1. Analgesic preparations
    2. Pharmaceutical preparations for the treatment of inflammatory diseases
    3. Pharmaceutical preparations for the treatment of inflammation
    4. Pharmaceutical preparations for the treatment of dupuytren's disease
    5. Pharmaceutical preparations for the treatment of frozen shoulder
    6. Pharmaceutical preparations for the treatment of post-operative delirium
    7. Pharmaceutical preparations for the treatment of post-operative cognitive deficit
    8. Pharmaceutical preparations for the treatment of post-operative cognitive decline
    9. Pharmaceutical preparations for the treatment of non-alcoholic steatohepatitis
    10. Pharmaceutical preparations for the treatment of fibrosis
    11. Pharmaceutical preparations for the treatment of liver fibrosis
    12. Pharmaceutical preparations for the treatment of arthritis
    13. Pharmaceutical preparations for the treatment of pain
    14. Pharmaceutical preparations for the treatment of ulcerative colitis
    15. Pharmaceutical preparations for the treatment of anxiety
    16. Pharmaceutical preparations for the treatment of type 1 diabetes
    17. Pharmaceutical preparations for the treatment of type 2 diabetes
    18. Pharmaceutical preparations for inhibition of tumor necrosis factor (tnf)
    19. Pharmaceutical preparations for interacting with nicotine receptors
    20. Pharmaceutical preparations for synthetically simulating non-psychoactive effects of cannabidiol (cbd)
    21. Pharmaceutical preparations for liver regeneration
    22. Pharmaceutical preparations for regenerative therapy
    23. Pharmaceutical preparations for acting as an alpha-7nachr agonist.
  • The mark was filed in class 42 with following description of goods:
    1. Development of pharmaceutical preparations and medicines
    2. Pharmaceutical drug development services
    3. Pharmaceutical product evaluation
    4. Pharmaceutical research and development
    5. Providing medical and scientific research information in the field of pharmaceuticals and clinical trials
    6. Research and development in the pharmaceutical and biotechnology fields
    7. Scientific research for medical purposes in the field of inflammatory diseases
    8. Scientific research for medical purposes in the field of treatment of inflammation
    9. Scientific research for medical purposes in the field of dupuytren's disease
    10. Scientific research for medical purposes in the field of frozen shoulder
    11. Scientific research for medical purposes in the field of post-operative delirium, post-operative cognitive deficit, and post-operative cognitive decline
    12. Scientific research for medical purposes in the field of non-alcoholic steatohepatitis
    13. Scientific research for medical purposes in the field of fibrosis
    14. Scientific research for medical purposes in the field of liver fibrosis
    15. Scientific research for medical purposes in the field of arthritis
    16. Scientific research for medical purposes in the field of pain treatment
    17. Scientific research for medical purposes in the field of ulcerative colitis
    18. Scientific research for medical purposes in the field of treatment of anxiety
    19. Scientific research for medical purposes in the field of inhibition of tumor necrosis factor (tnf) and anti-tnf pharmaceuticals
    20. Scientific research for medical purposes in the field of interactions with nicotine receptors
    21. Scientific research for medical purposes in the field of synthetic simulation of non-psychoactive effects of cannabidiol (cbd)
    22. Scientific research for medical purposes in the field of synthetic cannabidiol (cbd) analogs
    23. Scientific research for medical purposes in the field of type 1 diabetes
    24. Scientific research for medical purposes in the field of type 2 diabetes
    25. Scientific research for medical purposes in the field of liver regeneration
    26. Scientific research for medical purposes in the field of regenerative therapy
    27. Scientific research for medical purposes in the field of alpha-7nachr agonists.
Trademarkers